SMA News Today Forums & Multimedia Director Michael Morale discusses the breaking news Zolgensma (AVXS-101) Under Priority FDA Review as Possible Gene Therapy for SMA Type 1.
Read the full report here: https://smanewstoday.com/2018/12/04/zolgensma-avxs-101-under-priority-fda-review-as-possible-gene-therapy-for-sma-type-1/
